Impact of an antiemetic protocol on postoperative nausea and vomiting in children

R Drake1, B J Anderson, M A Persson

  • 1Department of Paediatrics, Auckland Children's Hospital, Grafton, Auckland, New Zealand.

Paediatric Anaesthesia
|December 21, 2000
PubMed

Insights

A new antiemetic protocol significantly reduced moderate to severe postoperative nausea and repeated nausea in children undergoing surgery. The protocol improved antiemetic prescribing, enhancing patient outcomes and satisfaction.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery
  • Pharmacology

Background:

  • Postoperative nausea and vomiting (PONV) is a common complication in pediatric surgery.
  • Effective management of PONV is crucial for patient recovery and satisfaction.

Purpose of the Study:

  • To evaluate the impact of a formalized antiemetic protocol on the incidence of PONV in children.
  • To assess changes in antiemetic prescribing patterns and patient satisfaction post-protocol implementation.

Main Methods:

  • A prospective, interview-based survey comparing PONV incidence before and after protocol introduction.
  • Monitoring of nausea, emesis, antiemetic use, and patient satisfaction in children aged 1.5-15 years.
  • Multivariate analysis to control for confounding factors like gender, surgery type, and opioid use.

Main Results:

  • The antiemetic protocol led to a significant decrease in moderate to severe postoperative nausea (18% vs. 9%) and repeated nausea (17% vs. 8%).
  • Antiemetic prescribing frequency increased significantly (10% vs. 59%) post-protocol.
  • While moderate to severe vomiting and repeated vomiting showed a downward trend, they did not reach statistical significance.

Conclusions:

  • Implementation of a formalized antiemetic protocol effectively reduced moderate to severe nausea and repeated nausea in pediatric patients.
  • The protocol improved antiemetic prescribing practices, contributing to better PONV management.
  • High patient satisfaction was maintained in both pre- and post-protocol groups.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...